George Patrick Jones - 04 Mar 2026 Form 4 Insider Report for Biofrontera Inc. (BFRI)

Signature
/s/ Daniel Hakansson, Attorney-in-fact for George Jones
Issuer symbol
BFRI
Transactions as of
04 Mar 2026
Net transactions value
$0
Form type
4
Filing time
06 Mar 2026, 21:26:24 UTC
Previous filing
16 Sep 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Jones George Patrick Chief Commercial Officer 660 MAIN STREET, FIRST FLOOR, WOBURN, /s/ Daniel Hakansson, Attorney-in-fact for George Jones 06 Mar 2026 0002085560

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BFRI Restricted Stock Units Award +50,000 $0.000000* 50,000 04 Mar 2026 Common Stock 50,000 Direct F2, F3
transaction BFRI Employee stock option (right to buy) Award +50,000 $0.000000* 50,000 04 Mar 2026 Common Stock 50,000 $0.9000 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in two equal installments, the first of which will take place on September 4, 2026 and the second of which will take place on March 4, 2027.
F2 Each restricted stock unit represents a contingent right to receive one share of BFRI common stock, subject to the company's discretion to settle the restricted stock units, in whole or in part, in cash, as discussed below in footnote 3. The reporting person received the restricted stock units as an award for no consideration.
F3 The restricted stock units vest in two equal yearly installments for the first two years following the grant date, beginning on March 4, 2027. Each vested restricted stock unit will be settled, at the Company's discretion, in shares, cash or a combination of shares and cash within 60 days of the vesting date.
F4 Options with different terms are not included